Krysiak Robert, Okopień Bogusław, Herman Zbigniew Stanisław
Katedra Farmakologii, Zakład Farmakologii Klinicznej Slasskiej Akademii Medycznej w Katowicach.
Pol Merkur Lekarski. 2006 Feb;20(116):214-9.
Resistance to thyroid hormones (RTH) is an inherited syndrome characterised by reduced target tissue responsiveness to these hormones. In the recent years, it has become clear that RTH is probably much more common than is generally recognised, and is often misdiagnosed and inaccurately treated. Subjects suffering from RTH have raised serum thyroid hormone levels and raised or inappropriately normal thyrotropin levels. Two major forms of a clinical presentation of this disorder are asymptomatic or slightly symptomatic subjects with generalised resistance and patients with thyrotoxic features suggesting predominant pituitary resistance. Surprisingly, these various clinical situations are determined by the same genetic defect. In this paper, aetiology, symptoms, clinical classification, diagnosis and treatment of RTH are reviewed with putting special emphasis on the results of recently published studies.
甲状腺激素抵抗(RTH)是一种遗传性综合征,其特征是靶组织对这些激素的反应性降低。近年来,越来越清楚的是,RTH可能比普遍认为的更为常见,并且经常被误诊和治疗不当。患有RTH的受试者血清甲状腺激素水平升高,促甲状腺激素水平升高或异常正常。这种疾病临床表现的两种主要形式是无症状或症状轻微的全身性抵抗受试者以及具有甲状腺毒症特征的患者,提示主要为垂体抵抗。令人惊讶的是,这些不同的临床情况是由相同的基因缺陷决定的。本文回顾了RTH的病因、症状、临床分类、诊断和治疗,并特别强调了最近发表的研究结果。